GGrantIndex
Sort

326,823 grants matching clinical trial

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

$1,730,801
S Louis Bridges · University Of Alabama At Birmingham · RC2 · FY2009 · AR

Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh

$1,730,751
Jiayi Yu · 21medtech Llc · R44 · FY2021 · GM

ADULT AIDS CLINICAL TRIALS UNIT

$1,730,607
Henry H. Balfour · University Of Minnesota · U01 · FY2006 · AI

Dissemination and Training Core

$1,730,565
Bethany C. Bray · University Of Michigan At Ann Arbor · P50 · FY2022 · DA

Drug Induced Liver Injury Network Data Coordinating Center

$1,730,418
Huiman X Barnhart · Duke University · U01 · FY2025 · DK

Delaware Christiana Care NCORP

$1,730,409
Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2022 · CA

Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis Complex

$1,730,358
Martina Bebin · University Of Alabama At Birmingham · U01 · FY2017 · NS

Preclinical Development of LIGO-069-136, An Anti-Inflammatory Pulmonary Therapeut

$1,730,286
Robert Frost Bargatze · Takeda Vaccines, Inc. · R44 · FY2007 · AI

Durban International Clinical Trials Unit

$1,729,976
Umesh G Lalloo · University Of Kwazulu-Natal · U01 · FY2008 · AI

Soft Tissue Sarcoma Program Project

$1,729,965
Samuel Singer · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Mechanisms of Peripheral Induction of T-cell Tolerance

$1,729,938
Kristin A. Hogquist · University Of Minnesota · P01 · FY2016 · AI

Pre-clinical Translational Research Facility

$1,729,889
Mark Gilbert · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Center for Lupus Research

$1,729,826
Maria Virginia Pascual · Baylor Research Institute · P50 · FY2016 · AR

Clinical Vector for TCR Immunotherapy Targeted to Melanoma

$1,729,819
Boro Dropulic · Lentigen Corporation · R44 · FY2012 · CA

ADULT AIDS CLINICAL TRIALS UNIT

$1,729,811
University Of California San Francisco · U01 · FY2001 · AI

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,729,738
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Elafin Therapy for Pulmonary Arterial Hypertension

$1,729,729
Marlene Rabinovitch · Stanford University · P01 · FY2020 · HL

Elafin Therapy for Pulmonary Arterial Hypertension

$1,729,729
Marlene Rabinovitch · Stanford University · P01 · FY2021 · HL

SPIROMICS Clinical Center

$1,729,657
Richard E Kanner · University Of Utah · N01 · FY2010 · HL

Nutritional Primary Prevention of Type 1 Diabetes

$1,729,497
Dorothy J Becker · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2008 · HD

Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease

$1,729,411
Clinton H. Joiner · Emory University · U01 · FY2014 · HL

Office for Scientific Operations

$1,729,409
Janelle Hauserman · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIJ · FY2023 · AR

VTEU: Natural History Study of Zika Virus

$1,729,319
Mark Joseph Mulligan · Emory University · N01 · FY2016 · AI

The LIMIting AAA with meTformin (LIMIT) Trial

$1,729,290
Ronald L Dalman · Stanford University · R33 · FY2022 · HL

The National Drug Abuse Treatment Clinical Trials Network

$1,729,183
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2013 · DA